Lucid Diagnostics Inc. (LUCD)
NASDAQ · Manufacturing · Surgical & medical instruments & apparatus
$0.8280−$0.0100 (−1.19%) on the dayAs of the close; data may be delayed.
LUCD price, last 12 months
Key stats
- Previous close
- $0.8380
- Open
- $0.8808
- Day range
- $0.8158 – $0.8808
- 52-week range
- $0.7500 – $1.63
- Volume
- 1.1M
- Avg volume (20 days)
- 1.1M
- Market cap
- $157.7M
Performance
1W+5.4%
1M−14.7%
3M−23.3%
6M−28.0%
YTD−24.0%
1Y−20.4%
vs S&P 500, 1Y−37.2 pts
Technicals and fundamentals
About Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
- Sector
- Manufacturing
- Industry
- Surgical & medical instruments & apparatus
- Listed on
- NASDAQ
- Market cap
- $157.7M